ARTICLE | Company News
Compugen management update
June 8, 2009 7:00 AM UTC
Compugen Ltd. (NASDAQ:CGEN), Tel Aviv, Israel Business: Gene/Cell therapy, Diagnostic, Computational chemistry/biology Promoted: Anat Cohen-Dayag to co-CEO from VP of R&D Transitioned: Martin Gerstel ...